Showing posts with label All the Written Testimony and Documents Are Available Now for the Hearing: Reforming the Drug Compounding Regulatory Framework Subcommittee on Health (Committee on Energy and Commerce)- July 16. Show all posts
Showing posts with label All the Written Testimony and Documents Are Available Now for the Hearing: Reforming the Drug Compounding Regulatory Framework Subcommittee on Health (Committee on Energy and Commerce)- July 16. Show all posts

Tuesday, July 16, 2013

All the Written Testimony and Documents Are Available Now for the Hearing: Reforming the Drug Compounding Regulatory Framework Subcommittee on Health (Committee on Energy and Commerce)- July 16, 2013

Hearing: Reforming the Drug Compounding Regulatory Framework
Subcommittee on Health (Committee on Energy and Commerce)

Tuesday, July 16, 2013 (3:00 PM)
2123 RHOB
Washington, D.C. 20515-20515

Witnesses

Dr. Carmen A. Catizone 
Executive Director, National Association of Boards of Pharmacy, Mount Prospect, IL
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Mr. Allan Coukell 
Deputy Director, Medical Programs, The Pew Charitable Trusts, Washington, D.C.
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Mr. Jeffrey K. Francer 
Assistant General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, D.C.
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Dr. David Gaugh 
Vice President, Regulatory Sciences, Generic Pharmaceutical Association, Washington, D.C.
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Dr. B. Douglas Hoey 
Chief Executive Officer, National Community Pharmacists Association, Alexandria, VA
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Dr. David G. Miller 
Executive Vice President and CEO, International Academy of Compounding Pharmacists, Alexandria, VA
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Dr. Kasey K. Thompson 
Vice President, Planning and Communication, American Society of Health-System Pharmacists, Bethesda, MD
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Truth in Testimony [PDF]
  • Witness Biography [PDF]
Dr. Janet Woodcock 
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Added 07/12/2013 at 02:22 PM
  • Witness Statement [PDF]
  • Witness Invitation [PDF]
  • Witness Biography and Truth in Testimony [PDF]

Text of Legislation

  • H.R. 2186--To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products [PDF]Added 07/12/2013 at 02:15 PM
  • S. 959--To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding drugs [PDF]Added 07/12/2013 at 02:15 PM
  • Discussion Draft--To amend section 503A of the Federal Food, Drug, and Cosmetic Act with respect to pharmacy compounding [PDF]Added 07/12/2013 at 02:15 PM

Support Documents

  • Hearing Notice [PDF]
  • Hearing Memo [PDF]Added 07/12/2013 at 03:33 PM
  • Hearing Room Change Notice [PDF]Added 07/15/2013 at 04:45 PM
    Source found here